the first 24 hours
The first 24 hours or the
management of the hyper-acute stroke patient is critical and
is likely to be the main reason that improvements in acute care and
early transfer to a dedicated stroke unit produces good reductions in
morbidity and mortality.
Thrombolysis will be dealt
in a later section but improving the outcome for the 90% or
more of patients that will never be thrombolysed is an essential part
of the management of the acute stroke and is outlined below.
Any
suggestions or comments will be gratefully received.
Stylised
image showing likely infarcted tissue (white) and surrounding penumbra
(dark brown)
Courtesy of
Internet Stroke Centre
Initial
assessment
It is important to make
the diagnosis correctly as early as possible. Stroke is a
clinical diagnosis not a radiological one and it is not always an easy
diagnosis to make. Certainly our experience of running TIA
clinics is that it is a diagnosis that is made incorrectly (with the
benefit of hindsight of course) up to 50% of the time by A&E
and GPs
Stroke physicians and neurologists
themselves are by no means infalliable either and small studies have
shown small but significant disagreements about both clincial signs and
likely vascular territory of strokes and TIAs.
It is
important (and reassuring therefore) to determine the likely area of
the brain affected by a stroke and be able to tie all the neurological
signs to that single area of the brain. Multiple simultaneous
strokes are extremly rare and signs that sugggests this should make one
suspicious and consider again other possible diagnoses.
A
stroke on the background of one or more previous strokes can be
challenging and clarity in the diagnosis may depend more on
radiological investigations.
Immediate
treatment
Aspirin
300 mg as a stat
dose (which can be oral or PR) is recognised as standard therapy in
ischaemic strokes followed by 75-150mg once a day after this. Subsets
of the data from IST show that you do not need to wait for a CT in
order to start this therapy. No significant harm will come to those
patients that then turn out to have a cerebral haemmorhage provided the
aspirin is then stopped. The ischaemic strokes meanwhile will
benefit from a 1% reduction in mortality as a result of early treatment.
In
centres and countries where the wait for a CT scan is likely to be
minimal then most physicians elect to wait for the scan result first.
This seems a reasonable course of action if the delay is
short.
However if the CT scan will be delayed significantly and the
diagnosis is clincially likely to be a infarction rather than a
haemmorhage then early treatment with aspirin is generally recommended.
Treatment
of hypoxia / hyperthermia / hyperglycaemia
It
is recognised that the cascade that results in irreversible nerve cell
death occurs promptly after a stroke. There is however an
area of
brain tissue around the infarction, often referred to as the penumbra,
which is at risk but is still potentially salvagable. Careful
management of oxygen saturations with supplemental oxygen, treatment of
hyperglycaemia with intravenous sliding scales of insulin, and reducing
pyrexias with regular paracetamol / cooling / treating underlying
infections is likely to be responsible for the improvements that good
acute stroke care seems to generate.
More acute
stroke units are
recognising that continous physiological monitoring is essential to
detect derrangements of normal physiological variables in sick stroke
patients and are moving to system which allow this. Oxygen
desaturations and rhythm disturbances are particularly likely to be
missed in the event of very infrequent monitoring regimes.
Hypertension
(in the acute setting)
It
is unclear still (trials are awaited) as to how hypertension should be
managed in the first day or two of an new stroke. Certainly
there
is a real risk that acutely lowering a patient's BP, with the loss of
cerebral autoregulation that occurs, could extend the stroke further.
It is also recognised that hypertension which is rarely
absent in
new stroke patients often settles after the first 24-48 hours to a
level much lower than on presentation.
Unfortunately
hypertension in acute stroke is significantly associated with a risk of
recurrent stroke not only long-term but in the short term (i.e the
first 14 days). On top of this uncontrolled hypertension is
associated with both an increased risk of cerebral oedema and
haemmorhagic transofrmation of infarctions.
Common
practice is
to not start or stop antihypertensive drugs for the first 48 hours
unless there is a cerebral haemmorhage when treatment perhaps should be
initiated in very hypertensive patients (i.e >200mmHg systolic)
or
in patients where there is either a hypertensive encephalopathy or
cardiovascular emergency such as MI or aortic dissection.
Artificial
food and fluids
Simple
swallowing assessments can be undertaken by trained professional at the
bedside (a formal SALT assessment may not be possible until the next
working day). Patients who pass this assessment should avoid
the
common practice of making all stroke patients NBM provided care and
observation of their feeding continues. Patients who fail
this
assessment will need a formal SALT assessment and IV fluids until oral
intake is established.
There is not an immediate
need to insert
a NG tube in patients who fail their swallow assessments as there is a
significant risk associated with the procedure and many patients will
improve enough to eat within 48 hours. If after this there is
not
sufficient intake, in patients who are expected to progress, NG feeding
is advisable. PEG tubes should be considered only if there is
no
improvement in the patient's swallow after three weeks or in the case
of multiple NG failures and the patients is still expected to survive.
Withdrawal of artificial food and / or fluids can be
considered
in those patients expected to deterioate despite treatment though these
are exceptionally difficult decisions and should be discussed with the
multi-disciplinary team and family members where possible.
Initial Investigations
FBC
/ ESR
U&E /Glucose
Random total cholesterol
ECG
/ CXR
CT Brain
Consider
depending on presentation, history and previous results
Vasculitic
screen
Auto-immune screen
Carotid dopplers
MRI
Brain
Echocardiography
Contrast Echocardiography
Rarely
Arch
Aortogram
EEG